LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

Clinical trial NCT07234695 · RECRUITING

Trial details

NCT number: NCT07234695
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Down Syndrome Down Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer Dementia Alzheimer Dementia (AD)Alzheimer Disease Alzheimer Disease (AD)Alzheimer Blood Biomarkers Epilepsy Seizures

Start date: 2025-12-22
Primary completion: 2027-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.